Surveillance for liver complications after the Fontan procedure
- 31 January 2017
- journal article
- review article
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 12 (2) , 124-132
Abstract
The physiological consequences of the Fontan circulation impose risk for hepatic dysfunction and may culminate in hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Consensus regarding appropriate surveillance modalities to diagnose liver disease in Fontan patients is lacking, in part due to the relative lack of strong evidence and prospective studies in this patient population. The goal of this paper is to critically review the current evidence and provide recommendations for the surveillance of hepatic complications in the post-Fontan patient population.Keywords
This publication has 63 references indexed in Scilit:
- Liver Disease in Patients After the Fontan OperationThe American Journal of Cardiology, 2016
- 40-Year Follow-Up After the Fontan OperationJACC, 2015
- Survival Data and Predictors of Functional Outcome an Average of 15 Years after the Fontan Procedure: The Pediatric Heart Network Fontan CohortCongenital Heart Disease, 2014
- Failure of the Fontan CirculationHeart Failure Clinics, 2014
- Hepatocellular Carcinoma after the Fontan ProcedureNew England Journal of Medicine, 2013
- Congenital heart disease and the liverHepatology, 2012
- Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan SurgeryCirculation, 2008
- Fontan Operation After 3 DecadesCirculation, 2008
- Long-Term Results of the Fontan OperationPediatric Cardiology, 2007
- The modified fontan procedure: early and late results in 132 adult patientsThe Journal of Thoracic and Cardiovascular Surgery, 2003